Bernt Johan von Scholten

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode et al. · The Lancet Diabetes & Endocrinology · 2021 · 178 citations · Full text

Medicine, Endocrinology, Immunology +16

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Johannes F.E. Mann, Vivian Fonseca, Ofri Mosenzon et al. · Circulation · 2018 · 145 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

Regitse Højgaard Christensen, Bernt Johan von Scholten, Christian Stevns Hansen et al. · Cardiovascular Diabetology · 2019 · 113 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

The effect of liraglutide on renal function: A randomized clinical trial

Bernt Johan von Scholten, Frederik Persson, Signe Rosenlund et al. · Diabetes Obesity and Metabolism · 2016 · 103 citations

Pharmacy, Pharmacology, Pharmacotherapy +17